Results 91 to 100 of about 12,125,335 (363)

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

open access: yesMolecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak   +4 more
wiley   +1 more source

The Experience of Use General Air Cryotherapy for Correction of Psoriasis

open access: yesМедицинский вестник Юга России, 2012
Purpose: We investigated the efficacy and safety of general air cryotherapy with addition of the moisturizing agent Xemose cream (Uriage cosmetic line) for correction of psoriasis.
Ya. Yu. Solonchenko   +2 more
doaj  

Safety and efficacy of fluticasone propionate in the topical treatment of skin diseases [PDF]

open access: yes, 2004
Fluticasone propionate - the first carbothioate corticosteroid - has been classified as a potent anti-inflammatory drug for dermatological use. It is available as 0.05% cream and 0.005% ointment formulations for the acute and maintenance treatment of ...
Atsuta J   +33 more
core   +1 more source

Skin diseases are more common than we think: screening results of an unreferred population at the Munich Oktoberfest

open access: yesJournal of the European Academy of Dermatology and Venereology, 2019
Skin diseases are ranked as the fourth most common cause of human illness, resulting in an enormous non‐fatal burden. Despite this, many affected people do not consult a physician.
L. Tizek   +7 more
semanticscholar   +1 more source

Psychosocial impact of skin diseases: A population-based study

open access: yesPLoS ONE, 2020
Background While it is well established that skin disease places significant psychosocial burden on a patient’s wellbeing, its effects have rarely been examined in Asian populations.
Y. Yew   +4 more
semanticscholar   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

High Glucosinolate Mustard and Potato Trial [PDF]

open access: yes, 2013
High glucosinolate mustard (HGM) can be planted as a cover crop to suppress weeds and disease. Studies have shown a reduction in soil-borne diseases, as well as advantages in mitigating weed pressure, after planting HGM cover crops.
Cummings, Erica   +3 more
core   +1 more source

Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases

open access: yesFrontiers in Immunology, 2019
Tyrosine kinases relay signals from diverse leukocyte antigen receptors, innate immune receptors, and cytokine receptors, and therefore mediate the recruitment and activation of various leukocyte populations. Non-receptor tyrosine kinases of the Jak, Src,
K. Szilveszter, T. Németh, A. Mócsai
semanticscholar   +1 more source

Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma

open access: yesMolecular Oncology, EarlyView.
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken   +7 more
wiley   +1 more source

Somatic Variants of KRT1/KRT10 Identified by Next-generation Sequencing in Patients with Epidermal Nevi

open access: yesActa Dermato-Venereologica
is missing (Short communication)
Shuya Sun   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy